⌘K

Home/Filings/4/0001824293-22-000056

4//SEC Filing

Ammer Richard 4

Accession 0001824293-22-000056

CIK 0001824293other

View on SEC.gov Company Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 1:32 PM ET

Size

5.4 KB

Accession

0001824293-22-000056

Insider Transaction Report

Form 4

Period: 2022-06-09

Vallon Pharmaceuticals, Inc.VLON

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-09+7,500→ 7,500 total
Exercise: $0.51Exp: 2032-06-09→ Common Stock (7,500 underlying)

Footnotes (1)

[F1]The stock option vests in four equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant.

Documents

1 file

4
wf-form4_165488232409421.xmlPrimary
FORM 4

Issuer

Vallon Pharmaceuticals, Inc.

CIK 0001824293

Entity typeother

Related Parties

1

filerCIK 0001843671

Filing Metadata

Form type: 4
Filed: Jun 9, 8:00 PM ET
Accepted: Jun 10, 1:32 PM ET
Size: 5.4 KB

View on SEC.gov